Shinoda Shuhei相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Lumen-apposing metal stent for peripancreatic fluid collection contributes to early improvement of nutritional status: A multicenter retrospective study (YCR-P001)

用于治疗胰周积液的管腔对接金属支架有助于早期改善营养状况：一项多中心回顾性研究（YCR-P001）

期刊:Medicine

影响因子:1.4

doi:10.1097/MD.0000000000048020

Tsuyama, Takanori; Suenaga, Shigeyuki; Suehiro, Harumi; Shinagawa, Ukyo; Hamamoto, Kaori; Tabara, Shoko; Shinoda, Shuhei; Amano, Shogo; Sen-Yo, Manabu; Ishigaki, Noriko; Kawano, Michitaka; Harima, Hirofumi; Takami, Taro

发表日期：2026

文献求助收藏

Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis.

抑制脂肪酸结合蛋白可抑制胰腺癌的进展和转移

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-11271-9

Shinoda Shuhei, Nakamura Naohiko, Inoko Kazuho, Sato-Dahlman Mizuho, Carmella Steven, Hecht Stephen, Bernlohr David A, Ikramuddin Sayeed, Yamamoto Masato

发表日期：2025

文献求助收藏

Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy.

开发一种由 CDX2 启动子控制的新型溶瘤腺病毒用于食管腺癌治疗

期刊:Journal of Gastroenterology

影响因子:5.5

doi:10.1007/s00535-024-02147-2

Nakamura Naohiko, Shinoda Shuhei, Sato-Dahlman Mizuho, Roach Brett, Jacobsen Kari, Yamamoto Masato

发表日期：2024

文献求助收藏

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

更正：口服铁螯合剂地拉罗司抑制胰腺癌侵袭

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-023-11091-y

Amano, Shogo; Kaino, Seiji; Shinoda, Shuhei; Harima, Hirofumi; Matsumoto, Toshihiko; Fujisawa, Koichi; Takami, Taro; Yamamoto, Naoki; Yamasaki, Takahiro; Sakaida, Isao

发表日期：2023

文献求助收藏

Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

撤稿声明：口服铁螯合剂地拉罗司抑制胰腺癌侵袭

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-023-11677-6

Amano, Shogo; Kaino, Seiji; Shinoda, Shuhei; Harima, Hirofumi; Matsumoto, Toshihiko; Fujisawa, Koichi; Takami, Taro; Yamamoto, Naoki; Yamasaki, Takahiro; Sakaida, Isao

发表日期：2023

文献求助收藏

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia

一例多发性胰高血糖素瘤，尽管存在高胰高血糖素血症，但无胰高血糖素过多的临床表现。

期刊:DEN Open

影响因子:1.5

doi:10.1002/deo2.230

Amano, Shogo; Suenaga, Shigeyuki; Hamamoto, Kaori; Yada, Shoko; Tsuyama, Takanori; Shinoda, Shuhei; Tanaka, Yuya; Takemoto, Yoshihiro; Harada, Eijiro; Tanabe, Katsuya; Asahara, Shunichiro; Hoshii, Kazunobu; Takami, Taro

发表日期：2023

文献求助收藏

Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery

肥胖与胰腺癌：流行病学、机制和减肥手术的最新进展

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines10061284

Shinoda, Shuhei; Nakamura, Naohiko; Roach, Brett; Bernlohr, David A; Ikramuddin, Sayeed; Yamamoto, Masato

发表日期：2022

文献求助收藏

Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2

脂肪酸结合蛋白4通过激活核因子E2相关因子2来调节胰腺癌细胞增殖

期刊:Surgery for Obesity and Related Diseases

影响因子:3.8

doi:10.1016/j.soard.2021.12.002

Wirth, Keith; Shinoda, Shuhei; Sato-Dahlman, Mizuho; Dickey, Deborah M; Bernlohr, David A; Ikramuddin, Sayeed; Yamamoto, Masato

细胞生物学

发表日期：2022

文献求助收藏

DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes

DHODH 抑制剂与 DNA 去甲基化剂协同作用治疗骨髓增生异常综合征

期刊:Blood Advances

影响因子:7.4

doi:10.1182/bloodadvances.2020001461

Kensuke Kayamori, Yurie Nagai, Cheng Zhong, Satoshi Kaito, Daisuke Shinoda, Shuhei Koide, Wakako Kuribayashi, Motohiko Oshima, Yaeko Nakajima-Takagi, Masayuki Yamashita, Naoya Mimura, Hans Jiro Becker, Kiyoko Izawa, Satoshi Yamazaki, Satoshi Iwano, Atsushi Miyawaki, Ryoji Ito, Kaoru Tohyama, William

发表日期：2021

文献求助收藏

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

地拉罗司是一种新型口服铁螯合剂，在体外和体内均显示出对胰腺癌的抗增殖活性。

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-016-2744-9

Harima, Hirofumi; Kaino, Seiji; Takami, Taro; Shinoda, Shuhei; Matsumoto, Toshihiko; Fujisawa, Koichi; Yamamoto, Naoki; Yamasaki, Takahiro; Sakaida, Isao

发表日期：2016

文献求助收藏